Link Between Vietnam Service And Prostate Cancer Is Statistically Insignificant
A report that appears in the March 2006 online issue of BMC Public Health focuses on the co-relation between men in the armed forces who served in Vietnam and the incidence of prostate cancer (CaP).// This co-relation exists since a defoliate called Agent Orange has been linked to CaP. However by Dr. Leavy and colleagues did not find a
statistically significant link between the two. Bet...
Neurologix Announces Publication of Landmark Gene Therapy Study
Demonstrating Safety and Statistically Significant Improvement in
Patients With Advanced Parkinson's Disease
FORT LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neurologix, Inc.(OTCBB:NRGX) today announced the publication in the June 23 issueof the journal The Lancet of positive results from the first evergene therapy trial for Parkinson's disease and the first report ofdirect gene transfer into a patient's own brain cells for any adultneurodegenerative disease. The open label Phase 1 study, conduct...
Medivation's Dimebon Maintains Statistically Significant Benefit on
All Five Efficacy Endpoints in Alzheimer's Disease Trial After One
Year of Therapy
- Aggregate Benefit over Placebo Larger at One Year than at SixMonths - SAN FRANCISCO and WASHINGTON, June 11, 2007/PRNewswire-FirstCall/ -- Medivation, Inc. today announced that thebenefits of Dimebon over placebo in its double-blind,placebo-controlled Phase 2 study in mild-to- moderate Alzheimer'sdisease were
statistically significant on all five study endpointsat 12 months. Importantl...
Repros' Androxal Shows Highly Statistically Significant Positive
Effects in Men with Secondary Hypogonadism
THE WOODLANDS, Texas--(BUSINESS WIRE)--Jun 5, 2007 - ReprosTherapeutics Inc. (NasdaqGM:RPRX) announced topline results of asix month U.S. Phase 3 study of Androxal(TM), an oral drug beingdeveloped to restore normal testicular function in men withsecondary hypogonadism. Further, Androxal demonstratesnon-inferiority in all the endpoints of the study, compared toAndrogel(R), a cream which is t...
ISTA Pharmaceuticals Announces Statistically Significant
Preliminary Results From its U.S. Phase II/III Clinical Study Of
Bepotastine
IRVINE, Calif., May 08, 2007 /PRNewswire-FirstCall/ -- ISTAPharmaceuticals, Inc., today announced results from the preliminaryanalysis of its U.S. Phase II/III clinical study of bepotastine forthe treatment of allergic conjunctivitis. The study evaluated twoconcentrations of bepotastine, each dosed once daily and twicedaily. The primary endpoints of the study were the assessment ofeffica...
EPIX Pharmaceuticals Announces Statistically Significant Results in
Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug
Candidate
LEXINGTON, Mass.--(BUSINESS WIRE)--Apr 18, 2007 - EPIXPharmaceuticals, Inc. (NASDAQ: EPIX) announced today positivecognitive function results from its Phase 1b multiple ascendingdose clinical trial of PRX-07034, the company'sinternally-discovered, novel 5-HT6 antagonist being developed forobesity, Alzheimer's disease and cognitive impairment associatedwith schizophrenia. The randomized,...
More>>